SWINE FLU VACCINE! | Arthritis Information

Share
 

Australian vaccine now approved by all ...

Available here from end of this month.
Approved for ages 16+ (meaning all adults & teens), not yet approved for children under 16
 
Australia will start distributing at the end of this month - first people to have it available to them will be healthcare workers, people with diabetes, ashma etc & others who have comprimised immune systems.
 
 
Not sure I would get one. It is a crap shoot at best.I'll be getting one.  Just had the flu shot and have never had any side effects.  People who have a secondary illness and/or a compromised immune system are at a greater risk of death from S1N1.  Lindysign me up..... I'm in.I had my regular flu shot a week ago and I am hoping I won't get sick before it kicks in... lots of flu here.  I can't imagine being sick right now!  I will probably get the H1N1 vacc., I am pretty worried about having any complications at this time.

Waddie HI Maz, thanks for the info, I will have it as whenever I get an infection its always the chest and usually progresses to pleurisy and sometimes pneumonia, so I am not taking any chances!  I have had the regular flu injection and have had no problems thank God, my GP said a while ago that my kids would have to have it due to Liam's immunity probs and Luke bringing home illnesses from school, will they get it Maz?  I know children aren't high risk so maybe they won't allow mine to have it?  Thanks Janie. Hi, Janie, 
Over here it is to be distributed hrough your GP, although remember it's not approved for children under 16 yet!
 
Hi Waddie,
I'm ok - they my doc changed my meds and I am doing fine, thanks for asking.
 
 
Just thought I would let everyone know FDA approved it this week and import to US is due asap
here in the US the H1nI vaccine is approved for all ages.  children/young adults  are a priority as they seem to be having more severe cases than the adults who get it.  Other priority groups include pregnant women, immuno suppressed, caregivers, first responders.  A bit unusual from the usual pattern is that those older than 65 seem to have some immunity already which that a form of this virus has already gone around in that population.
 
I think I'll wait until I can get both shots at the same time which should be sometime in Oct
buckeye2009-09-19 19:34:03The husband will be getting a flu shot at work in the next few weeks; the boys will get the flumist nasal vaccine at their upcoming checkups.  I'll see what the ped says about H1N1 at that time.  As for me, one of these days when I'm running errands I'll get a flu shot at Walgreens.  Haven't decided about H1N1 yet.  I have a dr appointment coming up at the end of October; I'll talk to him about it then.  Since the husband has some serious cardiac issues, the doc will probably want him to get the vaccination.  Hopefully they'll be doing H1N1 vaccinations at his office; otherwise can be difficult to get him to take time off to go to a dr's appointment. I still am not sure whether I will or wont get it. I keep going back and forth. UGH!The Australian vaccine IS a one dose shot!
 
This morning's news:
SWINE flu is killing children at twice the rate of seasonal flu, but under-10s will have to wait at least two months for the vaccine that is soon to be offered to every Australian adult in the nation's biggest immunisation scheme.

Health Minister Nicola Roxon yesterday announced that the first swine flu jabs would be given to adults from September 30. Health workers, indigenous people, pregnant women and people with underlying medical conditions such as asthma, cancer, HIV, heart disease, diabetes, chronic kidney failure and obesity would be given priority.

The medical watchdog, the Therapeutic Goods Administration, has ruled that a single dose of the CSL vaccine for the H1N1 virus is safe and effective in preventing swine flu infections among adults.

But a vaccine for children will not be available until at least November. Clinical trials are now being carried out on 400 children nationally.

The CDC hasn't quite made its mind up yet about the number of doses required:

"In previously unvaccinated persons aged <9 years, 2 doses of seasonal influenza vaccine are required to induce immunity because young children typically have had limited exposure to influenza viruses and are not immunologically primed (i.e., they do not have preexisting antibodies) (12). The lack of preexisting antibody cross-reactive with the novel influenza A (H1N1) virus among children and younger adults raises the possibility that 2 doses of vaccine (typically separated by ≥21 days) also will be needed to provide protection for persons in these age groups. Ongoing studies will provide additional information about the immune response vaccine, including which groups might need 2 doses. Updated information will be published by CDC in MMWR or will be available at http://www.cdc.gov/flu."


Recommended Use of Influenza A (H1N1) 2009 Monovalent Vaccine

ACIP recommends that vaccination efforts should focus initially on persons in five target groups (Box) whose members are at higher risk for influenza or influenza-related complications, are likely to come in contact with influenza viruses as part of their occupation and could transmit influenza viruses to others in medical care settings, or are close contacts of infants aged <6 months (who are too young to be vaccinated). In the event that vaccine availability is unable to meet initial demand, priority should be given to a subset of the five target groups (Box).

Initial Target Groups

When vaccine is first available, ACIP recommends that programs and providers administer vaccine to persons in the following five target groups (order of target groups does not indicate priority):

These five target groups comprise an estimated 159 million persons in the United States. This estimate does not accurately account for persons who might be included in more than one category (e.g., a health-care worker with a high-risk condition). Vaccination programs and providers should begin vaccination of persons in all these groups as soon as vaccine is available.

Subset of Target Groups During Limited Vaccine Availability

Current projections of initial vaccine supply indicate that establishment of a subset of the five initial target groups will not be necessary in most areas. However, demand for vaccination and initial supply might vary considerably across geographic areas. If the supply of the vaccine initially available is not adequate to meet demand for vaccination among the five target groups listed above, ACIP recommends that the following subset of the initial target groups receive priority for vaccination until vaccine availability increases (order of target groups does not indicate priority):

This subset of the five target groups comprises approximately 42 million persons in the United States. Vaccination programs and providers should give priority to this subset of the five target groups only if vaccine availability is too limited to initiate vaccination for all persons in the five initial target groups.

http://www.cdc.gov/mmwr/preview/mmwrhtml/rr58e0821a1.htm



I guess it depends on which vaccine the CDC uses -- or chooses to import, 
 
Must admit I really don't understand how your med people can categorically say they will give vaccines to children ?? 
 
 
[QUOTE=Maz-aust]I guess it depends on which vaccine the CDC uses -- or chooses to import,  Jas,
 
I must admit I don't understand your thinking.  
 
For you to suggest a fault in the decision, taken by our authorities, to delay administering the vaccine to children until it has been proven safe amazes me.  Surely any Government who wants to ensure a vaccine is safe before supplying it should be commended.  In our case (from the response) it is obvious the majority of parents agree.
 
I was under the impression that USA were going to import our vaccine & knowing it wasn't yet deemed to be safe for children how they could then agree in a press release that they would still distribute it.
 
 
 
Obviously you don't agree ...... 
[QUOTE=Maz-aust]Jas, The H1N1 vaccine in the USA will be from 4 different manufacturers:  CSL, Sanofi Pasteur, Medimmune, and Novartis.  I believe GSK has one in the works as well.
Copyright ArthritisInsight.com